Recorded: 29 May 2008
Yeah, so with stem cell therapy one would hope to [unintelligible] to repair defects in tissues that come about when you’re aging or when you have had a disease of any kind. Stem cells are in principle cells that can divide forever, so stem cells really resemble cancer, and cancer and stem cells are a really closely related phenomenon. So the big worry is when you transplant stem cells, or stem cell derived tissues into patients that residual stem cell activity will somehow lead to cancer for the patient. I guess that’s the biggest worry that doctors would have.
Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA.
From 1991-2002 Hans Clevers was Professor in Immunology at the University Utrecht and, since 2002, Professor in Molecular Genetics. Since 2002, he is director of the Hubrecht Institute in Utrecht.
Hans Clevers has been a member of the Royal Netherlands Academy of Arts and Sciences since 2000 and is the recipient of several awards, including the Dutch Spinoza Award in 2001, the Swiss Louis Jeantet Prize in 2004, the Memorial Sloan-Kettering Katharine Berkan Judd Award in 2005, the Israeli Rabbi Shai Shacknai Memorial Prize in 2006, and the Dutch Josephine Nefkens Prize for Cancer Research and the German Meyenburg Cancer Research Award in 2008. He obtained an ERC Advanced Investigator grant in 2008. He is Chevalier de la Legion d'Honneur since 2005.